PTGS2 and neoplasm: Molecular mediators such as NF-κB and cyclooxygenase-2 (COX-2) further modulate the inflammatory milieu, facilitating angiogenesis, tumor proliferation, and resistance to apoptosis, while also serving as potential markers of disease progression and therapeutic targets [131,132,133].